The market expects Beam Therapeutics Inc. (BEAM) to deliver a year-over-year increase in earnings on lower revenues when it ...

Does Relay Therapeutics, Inc. (RLAY) have what it takes to be a top stock pick for momentum investors? Let's find out.

NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) is one of the most profitable biotech stocks to buy. On October 20, Bank of America ...

Ratings for Protagonist Therapeutics (NASDAQ: PTGX) were provided by 7 analysts in the past three months, showcasing a mix of ...

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential.

BRIUMVI is currently approved in the United States, as well as several countries outside of the U.S., as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in ...

Celldex Therapeutics, Inc. has rallied over 70% off April 2025 lows, driven by optimism for lead candidate barzolvolimab in chronic urticaria. Learn more about CLDX stock here.

Akebia does not expect to initiate VALOR clinical trial following Type C meeting feedback from U.S. FDACAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a ...

Qualigen Therapeutics Inc. (NASDAQ: QLGN) ('Qualigen”, 'QLGN” or the 'Company”), a publicly-traded technology company majority owned by Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) ...